Bone Biologics (BBLG)

• Market cap: $2.14M
• 1 day: -2.46%
• 5 days: -14.39%
• 1 month: -26.99%
• 3 months: -30%
• 6 months: -49.36%
• Year to date: -22.73%
• 1 year: -80.74%
• 5 years: -99.98%
• 10 years: -99.98%
• Sector: Healthcare
• Industry: Biotechnology

About: Bone Biologics Corp is a healthcare solutions provider based in the United States. As a biotechnology firm, it engages its efforts in developing therapeutics to aid bone regeneration. The company's portfolio comprises its lead product, NELL-1, which is a bone void filler. Bone Biologics' technology has applications in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine.

Employees: 2